Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Christopher DeSouza

Concepts (402)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Endothelium, Vascular
46
2025
926
9.170
 Why?
Cell-Derived Microparticles
15
2025
62
8.920
 Why?
Vasodilation
30
2025
481
6.080
 Why?
Endothelin-1
17
2025
181
5.660
 Why?
Endothelial Cells
16
2025
744
4.260
 Why?
Vasoconstriction
14
2025
195
4.150
 Why?
Fibrinolysis
16
2023
136
3.450
 Why?
Human Umbilical Vein Endothelial Cells
8
2025
98
3.140
 Why?
Tissue Plasminogen Activator
18
2024
226
3.010
 Why?
Nitric Oxide
14
2024
896
2.830
 Why?
Vasodilator Agents
22
2025
325
2.790
 Why?
Hypertension
14
2023
1245
2.770
 Why?
Forearm
18
2021
119
2.690
 Why?
Sleep Deprivation
6
2021
171
2.690
 Why?
Obesity
20
2025
2869
2.610
 Why?
Overweight
9
2018
526
2.210
 Why?
Aging
39
2011
1785
2.210
 Why?
MicroRNAs
7
2025
680
2.200
 Why?
Nitric Oxide Synthase Type III
8
2024
206
2.110
 Why?
Spinal Cord Injuries
4
2023
191
2.030
 Why?
Exercise
34
2024
1941
1.890
 Why?
Acetylcholine
17
2025
185
1.830
 Why?
Prehypertension
5
2015
27
1.740
 Why?
Regional Blood Flow
24
2025
463
1.740
 Why?
Middle Aged
111
2025
31322
1.740
 Why?
Vasomotor System
2
2025
43
1.660
 Why?
Cardiovascular Diseases
11
2021
2028
1.590
 Why?
Apoptosis
15
2024
2519
1.580
 Why?
Blood Pressure
20
2021
1753
1.570
 Why?
HIV Envelope Protein gp120
3
2019
58
1.560
 Why?
Sleep
5
2021
673
1.530
 Why?
Polycythemia
2
2021
22
1.460
 Why?
Stem Cells
8
2012
585
1.430
 Why?
Postmenopause
18
2023
370
1.280
 Why?
NG-Nitroarginine Methyl Ester
3
2024
46
1.270
 Why?
Nitroprusside
16
2021
67
1.260
 Why?
tat Gene Products, Human Immunodeficiency Virus
2
2019
23
1.230
 Why?
Enzyme Inhibitors
6
2024
832
1.230
 Why?
Male
92
2025
63748
1.200
 Why?
Circulating MicroRNA
2
2019
25
1.200
 Why?
C-Reactive Protein
7
2015
396
1.190
 Why?
Metabolic Syndrome
4
2016
341
1.180
 Why?
Nebivolol
2
2017
10
1.100
 Why?
Cell Movement
8
2014
948
1.090
 Why?
Atherosclerosis
2
2023
407
1.080
 Why?
Humans
137
2025
130305
1.070
 Why?
Platelet Endothelial Cell Adhesion Molecule-1
3
2011
59
1.040
 Why?
Peptides, Cyclic
7
2013
258
1.040
 Why?
Caspase 3
5
2017
242
1.030
 Why?
Inflammation Mediators
5
2024
509
0.980
 Why?
Adult
68
2023
35711
0.930
 Why?
Vasoconstrictor Agents
6
2023
131
0.920
 Why?
Female
83
2025
68842
0.910
 Why?
Work-Life Balance
1
2024
17
0.910
 Why?
Fibrin Fibrinogen Degradation Products
2
2023
83
0.870
 Why?
Physical Endurance
16
2024
269
0.830
 Why?
Goals
1
2024
165
0.820
 Why?
Aged
64
2021
22282
0.810
 Why?
Dietary Fats
2
2015
303
0.810
 Why?
Blood Coagulation
2
2021
234
0.770
 Why?
Cells, Cultured
9
2024
4106
0.770
 Why?
Estrogen Replacement Therapy
9
2003
142
0.730
 Why?
Vascular Diseases
1
2023
243
0.710
 Why?
Altitude
3
2021
451
0.700
 Why?
Case-Control Studies
11
2021
3369
0.660
 Why?
Physical Fitness
12
2005
203
0.660
 Why?
Oxidative Stress
7
2021
1239
0.660
 Why?
Acclimatization
1
2021
161
0.650
 Why?
Cross-Sectional Studies
23
2023
5083
0.640
 Why?
Ascorbic Acid
3
2021
123
0.640
 Why?
Hemodynamics
8
2021
1099
0.640
 Why?
Telomere
3
2010
231
0.620
 Why?
T-Lymphocyte Subsets
2
2011
412
0.610
 Why?
Endothelium
3
2020
116
0.600
 Why?
Dose-Response Relationship, Drug
9
2017
1983
0.600
 Why?
Biomarkers
12
2025
3923
0.600
 Why?
Hematopoietic Stem Cells
2
2011
381
0.580
 Why?
Metoprolol
1
2017
39
0.570
 Why?
HIV
1
2019
225
0.570
 Why?
Blood Glucose
7
2019
2100
0.570
 Why?
Plethysmography
5
2017
110
0.560
 Why?
Hyperglycemia
2
2018
326
0.560
 Why?
Bradykinin
8
2015
46
0.540
 Why?
Receptor, Endothelin A
2
2014
63
0.540
 Why?
Stress, Physiological
2
2017
416
0.540
 Why?
HIV Infections
4
2019
2721
0.530
 Why?
Plasminogen Activator Inhibitor 1
7
2023
86
0.530
 Why?
Cellular Senescence
1
2018
177
0.520
 Why?
Cytokines
4
2020
2016
0.520
 Why?
Body Mass Index
15
2017
2268
0.510
 Why?
Nitric Oxide Synthase
4
2017
238
0.490
 Why?
Interleukin-6
6
2025
730
0.490
 Why?
Gender Identity
2
2006
115
0.480
 Why?
Blood Pressure Determination
2
2016
150
0.480
 Why?
Diet, High-Fat
2
2018
240
0.460
 Why?
Blood Platelets
1
2017
373
0.440
 Why?
Endothelial Progenitor Cells
1
2014
20
0.440
 Why?
Interleukin-8
3
2025
264
0.440
 Why?
Glucose
2
2017
989
0.430
 Why?
Analysis of Variance
7
2016
1291
0.420
 Why?
Adiposity
3
2016
507
0.420
 Why?
Infusions, Intra-Arterial
5
2013
54
0.410
 Why?
Colony-Forming Units Assay
6
2014
90
0.410
 Why?
Transcription Factor RelA
2
2024
85
0.400
 Why?
Inflammation
5
2025
2721
0.400
 Why?
Blood Vessels
1
2014
186
0.400
 Why?
Endothelin A Receptor Antagonists
4
2014
24
0.400
 Why?
Arteries
7
2018
269
0.400
 Why?
Alkalosis, Respiratory
2
2023
2
0.390
 Why?
Anti-HIV Agents
1
2019
750
0.390
 Why?
Oxygen Consumption
12
2024
680
0.390
 Why?
Coronary Disease
3
2007
392
0.390
 Why?
Body Composition
14
2009
658
0.380
 Why?
T-Lymphocytes
2
2010
1928
0.380
 Why?
Glucose Intolerance
1
2013
142
0.380
 Why?
Muscle, Smooth, Vascular
5
2010
437
0.370
 Why?
Time Factors
10
2021
6615
0.370
 Why?
Fatty Acids
1
2014
416
0.370
 Why?
Abdominal Fat
1
2011
40
0.360
 Why?
NF-kappa B
3
2025
691
0.360
 Why?
Young Adult
11
2023
12404
0.360
 Why?
Muscle Tonus
2
2010
19
0.360
 Why?
Antigens, CD34
1
2011
92
0.360
 Why?
Risk Factors
14
2018
9865
0.350
 Why?
HIV Protease Inhibitors
1
2011
63
0.350
 Why?
Dyslipidemias
1
2012
177
0.340
 Why?
Chemotaxis
1
2010
130
0.340
 Why?
HIV-1
2
2019
843
0.340
 Why?
Health
1
2010
74
0.330
 Why?
Cholesterol, LDL
1
2012
361
0.330
 Why?
Postprandial Period
3
2019
103
0.330
 Why?
Heart Failure
1
2023
2164
0.330
 Why?
Sleep Wake Disorders
1
2013
251
0.330
 Why?
Disease
1
2010
95
0.320
 Why?
Feeding Behavior
1
2015
621
0.320
 Why?
Flow Cytometry
4
2019
1158
0.310
 Why?
Vascular Endothelial Growth Factor A
4
2014
533
0.310
 Why?
Muscarinic Agonists
1
2008
17
0.300
 Why?
Phosphorylation
2
2024
1709
0.290
 Why?
Fasting
4
2019
265
0.280
 Why?
Reference Values
7
2016
793
0.280
 Why?
omega-N-Methylarginine
3
2015
26
0.280
 Why?
Exercise Therapy
4
2017
416
0.280
 Why?
Reactive Oxygen Species
2
2021
587
0.280
 Why?
Endothelin Receptor Antagonists
4
2011
62
0.270
 Why?
Adult Stem Cells
1
2006
37
0.260
 Why?
Dinucleotide Repeats
1
2005
4
0.250
 Why?
Epigenesis, Genetic
1
2010
620
0.240
 Why?
Double-Blind Method
5
2021
1878
0.240
 Why?
Hyperthermia, Induced
2
2023
109
0.240
 Why?
Myocardial Ischemia
1
2006
256
0.240
 Why?
Walking
5
2018
502
0.230
 Why?
Adipose Tissue
6
2005
593
0.230
 Why?
Premenopause
5
2002
127
0.230
 Why?
Estrogen Receptor alpha
1
2005
135
0.230
 Why?
Physiology
1
2024
13
0.230
 Why?
Signal Transduction
5
2025
4930
0.220
 Why?
Blood Flow Velocity
3
2012
413
0.220
 Why?
Endothelin B Receptor Antagonists
2
2014
11
0.220
 Why?
Quadriplegia
1
2023
12
0.220
 Why?
Age Factors
8
2010
3153
0.220
 Why?
Antihypertensive Agents
4
2013
489
0.220
 Why?
von Willebrand Factor
1
2023
63
0.220
 Why?
Carotid Arteries
5
2003
207
0.210
 Why?
Hypertrophy
2
2023
120
0.210
 Why?
Thrombophilia
1
2023
68
0.210
 Why?
Actinin
1
2023
14
0.210
 Why?
Troponin T
1
2023
58
0.200
 Why?
Contraceptives, Oral
1
2002
39
0.200
 Why?
Running
5
2000
229
0.200
 Why?
Career Choice
1
2024
212
0.200
 Why?
Vaping
1
2023
57
0.200
 Why?
Receptor, Endothelin B
2
2014
56
0.200
 Why?
Electronic Nicotine Delivery Systems
1
2023
91
0.190
 Why?
Sex Characteristics
4
2017
728
0.190
 Why?
Breathing Exercises
1
2021
20
0.190
 Why?
Respiratory Muscles
1
2021
32
0.190
 Why?
Inhalation
1
2021
30
0.190
 Why?
Colorado
6
2024
4471
0.180
 Why?
Estradiol
1
2025
498
0.180
 Why?
South America
1
2021
56
0.180
 Why?
Diet, Sodium-Restricted
1
2001
36
0.180
 Why?
Peru
1
2021
54
0.180
 Why?
Diet, Carbohydrate-Restricted
2
2018
32
0.180
 Why?
Lymphocyte Count
2
2011
150
0.180
 Why?
Endothelins
1
2021
61
0.180
 Why?
Healthy Lifestyle
1
2021
32
0.180
 Why?
Drug Administration Schedule
2
2016
766
0.180
 Why?
Transforming Growth Factor beta
1
2023
465
0.170
 Why?
Fibrosis
1
2023
529
0.170
 Why?
Cytochromes c
2
2010
61
0.170
 Why?
Tumor Necrosis Factor-alpha
3
2015
1210
0.170
 Why?
Diabetes Mellitus, Type 2
3
2019
2440
0.170
 Why?
Chemokine CXCL12
2
2010
79
0.170
 Why?
Fibrinogen
2
1998
159
0.170
 Why?
Piperidines
2
2013
191
0.170
 Why?
Oligopeptides
2
2013
258
0.160
 Why?
Fever
2
2020
303
0.160
 Why?
Physical Exertion
2
1998
215
0.160
 Why?
Insulin Glargine
1
2019
80
0.160
 Why?
Cell Proliferation
1
2006
2381
0.160
 Why?
Risk Reduction Behavior
1
2021
212
0.160
 Why?
E-Selectin
1
2018
54
0.160
 Why?
Hemoglobins
1
2021
345
0.150
 Why?
HIV Antibodies
1
2019
58
0.150
 Why?
Myocytes, Cardiac
1
2023
495
0.150
 Why?
Infusions, Intravenous
2
2011
395
0.150
 Why?
Telomerase
2
2011
233
0.150
 Why?
Phenotype
2
2021
3084
0.150
 Why?
Heat-Shock Response
1
2018
71
0.150
 Why?
Brachial Artery
3
2017
206
0.150
 Why?
Follow-Up Studies
3
2017
4961
0.150
 Why?
Antioxidants
1
2021
562
0.150
 Why?
Adrenergic beta-1 Receptor Antagonists
1
2017
11
0.150
 Why?
Pilot Projects
1
2023
1565
0.150
 Why?
Vascular Cell Adhesion Molecule-1
1
1997
42
0.140
 Why?
Biomedical Research
1
2024
658
0.140
 Why?
Lipids
3
2009
627
0.140
 Why?
Dietary Carbohydrates
1
2018
152
0.140
 Why?
Treatment Outcome
5
2021
10341
0.140
 Why?
Myocardial Infarction
1
2005
1036
0.140
 Why?
Intercellular Adhesion Molecule-1
1
1997
152
0.140
 Why?
Heart
1
2021
654
0.140
 Why?
Prognosis
3
2018
3830
0.130
 Why?
Infusions, Intraosseous
1
2016
18
0.130
 Why?
Anthropometry
2
2011
206
0.130
 Why?
Insulin
2
2005
2322
0.120
 Why?
Enzyme Activation
1
2017
817
0.120
 Why?
Triglycerides
3
2005
525
0.120
 Why?
Baroreflex
3
2001
61
0.120
 Why?
Substance P
2
2008
44
0.120
 Why?
Isoproterenol
2
2008
111
0.120
 Why?
Blood Circulation
1
2015
41
0.120
 Why?
Down-Regulation
1
2017
642
0.120
 Why?
Insulin Resistance
2
2003
1167
0.120
 Why?
Hot Temperature
1
2017
366
0.120
 Why?
Interleukin-18
2
2006
239
0.120
 Why?
Peptides
1
2019
917
0.110
 Why?
Cross-Over Studies
4
2017
521
0.110
 Why?
Regression Analysis
5
2011
991
0.110
 Why?
Physical Education and Training
2
2024
76
0.110
 Why?
Interleukin-10
1
2015
302
0.100
 Why?
Hydrocortisone
1
2015
301
0.100
 Why?
Cholinergic Agonists
1
2011
7
0.090
 Why?
Injections, Intravenous
1
2012
201
0.090
 Why?
Circadian Rhythm
1
2015
404
0.090
 Why?
Blood Volume
4
1999
61
0.090
 Why?
Obesity, Abdominal
1
2011
48
0.090
 Why?
Waist Circumference
1
2011
138
0.090
 Why?
Plaque, Atherosclerotic
1
2011
55
0.090
 Why?
Hypoglycemic Agents
1
2019
1218
0.090
 Why?
Vital Capacity
2
2002
289
0.090
 Why?
Femoral Artery
2
2002
176
0.090
 Why?
Apoptosis Regulatory Proteins
1
2011
183
0.090
 Why?
Prevalence
3
2014
2576
0.090
 Why?
Plant Lectins
1
2010
8
0.090
 Why?
Staurosporine
1
2010
20
0.080
 Why?
Cerebrovascular Circulation
2
2023
224
0.080
 Why?
Cholesterol
2
2005
407
0.080
 Why?
Estrogens
2
2003
355
0.080
 Why?
Aged, 80 and over
6
2003
7128
0.080
 Why?
Granulocyte Colony-Stimulating Factor
1
2010
72
0.080
 Why?
Bone Diseases, Metabolic
1
2010
60
0.080
 Why?
CD3 Complex
1
2009
102
0.080
 Why?
Immunoenzyme Techniques
1
2009
215
0.080
 Why?
Cell Separation
1
2010
317
0.080
 Why?
Life Style
5
2003
461
0.080
 Why?
Leg
2
2001
242
0.080
 Why?
Phosphatidylinositol 3-Kinases
1
2011
362
0.080
 Why?
Proto-Oncogene Proteins c-akt
1
2011
428
0.080
 Why?
Norepinephrine
1
2009
218
0.080
 Why?
Up-Regulation
1
2012
856
0.080
 Why?
Endothelin-Converting Enzymes
1
2008
10
0.080
 Why?
Aspartic Acid Endopeptidases
1
2008
26
0.080
 Why?
Metalloendopeptidases
1
2008
58
0.080
 Why?
Methacholine Chloride
1
2008
51
0.070
 Why?
Cell Count
1
2008
320
0.070
 Why?
Calcium Channel Blockers
1
2008
125
0.070
 Why?
Hemiplegia
2
1997
20
0.070
 Why?
Arm
1
2007
109
0.070
 Why?
Coronary Circulation
1
2007
138
0.070
 Why?
Risk Assessment
1
2016
3310
0.070
 Why?
Probability
1
2007
314
0.070
 Why?
Lipoproteins, LDL
1
2006
132
0.060
 Why?
Microscopy, Phase-Contrast
1
2005
16
0.060
 Why?
Thymidine
1
2005
58
0.060
 Why?
Muscle, Skeletal
3
2002
1642
0.060
 Why?
DNA Methylation
1
2010
610
0.060
 Why?
Weight Loss
1
2010
728
0.060
 Why?
Bone Marrow Cells
1
2005
300
0.060
 Why?
Anaerobic Threshold
2
2005
27
0.060
 Why?
France
1
2024
31
0.060
 Why?
Hypocapnia
1
2023
10
0.060
 Why?
Thrombosis
1
2007
337
0.060
 Why?
Hyperventilation
1
2023
9
0.060
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2008
423
0.060
 Why?
History, 21st Century
1
2024
184
0.050
 Why?
Adenine
1
2005
256
0.050
 Why?
Compliance
4
2008
50
0.050
 Why?
Oxidation-Reduction
1
2006
1018
0.050
 Why?
Body Weight
2
2005
938
0.050
 Why?
History, 20th Century
1
2024
297
0.050
 Why?
Muscarinic Antagonists
1
2003
27
0.050
 Why?
Fenofibrate
1
2003
30
0.050
 Why?
Hypertriglyceridemia
1
2003
39
0.050
 Why?
Bicycling
1
2024
118
0.050
 Why?
Heart Rate
4
2001
813
0.050
 Why?
Sensitivity and Specificity
1
2007
1854
0.050
 Why?
Polymorphism, Genetic
1
2005
643
0.050
 Why?
Exercise Test
3
2005
622
0.050
 Why?
Carotid Artery Diseases
1
2002
65
0.050
 Why?
Progesterone
1
2003
244
0.050
 Why?
Adrenergic beta-Agonists
1
2002
132
0.050
 Why?
Universities
1
2024
406
0.050
 Why?
Carbon Dioxide
1
2023
262
0.050
 Why?
Tunica Intima
4
2002
86
0.050
 Why?
Systole
1
2001
191
0.050
 Why?
Ultrasonography
5
2002
731
0.040
 Why?
Heart Conduction System
1
2001
94
0.040
 Why?
Cardiovascular Physiological Phenomena
1
2000
44
0.040
 Why?
Knee
1
2000
61
0.040
 Why?
Mexican Americans
1
2001
113
0.040
 Why?
Predictive Value of Tests
1
2005
1974
0.040
 Why?
Hemorheology
1
2018
21
0.040
 Why?
Oxygen
1
2024
919
0.040
 Why?
Energy Intake
2
1998
454
0.040
 Why?
Body Constitution
1
1998
53
0.040
 Why?
Social Class
1
2001
258
0.040
 Why?
Drug Combinations
1
2019
328
0.040
 Why?
Diet, Fat-Restricted
1
2018
79
0.040
 Why?
Hemostasis
1
1998
70
0.040
 Why?
Microvessels
1
2018
80
0.040
 Why?
Plasminogen Activators
1
1997
7
0.040
 Why?
Cervical Vertebrae
1
2018
130
0.040
 Why?
Vascular Resistance
1
1998
373
0.030
 Why?
Gait
2
1997
286
0.030
 Why?
United States
1
2014
14110
0.030
 Why?
Cohort Studies
1
2007
5431
0.030
 Why?
Movement Disorders
1
1997
53
0.030
 Why?
Cerebrovascular Disorders
1
1997
91
0.030
 Why?
Chromium
1
1996
13
0.030
 Why?
Weight Lifting
1
1996
34
0.030
 Why?
Leukocytes, Mononuclear
1
2018
550
0.030
 Why?
Neoplasms
1
2010
2467
0.030
 Why?
Gene Expression Regulation
1
2025
2549
0.030
 Why?
Combined Modality Therapy
1
2017
1219
0.030
 Why?
Hypoxia
1
2021
1075
0.030
 Why?
Antigens
1
1996
353
0.030
 Why?
Melatonin
1
2015
121
0.030
 Why?
Swimming
3
1999
47
0.030
 Why?
Randomized Controlled Trials as Topic
1
2019
1381
0.030
 Why?
Menopause
1
1997
303
0.030
 Why?
Defibrillators, Implantable
1
1997
296
0.030
 Why?
Brain Ischemia
1
1997
309
0.030
 Why?
Tunica Media
2
2001
38
0.020
 Why?
Sex Factors
1
1996
1965
0.020
 Why?
Animals
3
2024
35076
0.020
 Why?
Brain
1
2020
2629
0.020
 Why?
Cardiac Output
2
1998
159
0.020
 Why?
Prospective Studies
4
2001
7131
0.020
 Why?
Bone Density
1
2010
477
0.020
 Why?
Stroke Volume
2
1998
593
0.020
 Why?
Hemostatics
1
2005
48
0.010
 Why?
Adolescent
5
2002
20374
0.010
 Why?
Hypolipidemic Agents
1
2003
93
0.010
 Why?
Fatty Acids, Nonesterified
1
2003
159
0.010
 Why?
Lipoproteins
1
2003
172
0.010
 Why?
Absorptiometry, Photon
1
2002
250
0.010
 Why?
Blood Viscosity
1
2001
16
0.010
 Why?
Habits
1
2001
43
0.010
 Why?
Thoracic Arteries
1
2000
4
0.010
 Why?
Thigh
1
2000
54
0.010
 Why?
Mexico
1
2001
190
0.010
 Why?
Thinness
1
2000
90
0.010
 Why?
Erythrocyte Volume
1
1999
6
0.010
 Why?
Elasticity
1
2000
202
0.010
 Why?
Plasma Volume
1
1999
19
0.010
 Why?
Femur
1
2001
247
0.010
 Why?
Stress, Mechanical
1
2001
470
0.010
 Why?
Supine Position
1
1998
38
0.010
 Why?
Posture
1
1999
175
0.010
 Why?
Signal Processing, Computer-Assisted
1
1998
143
0.010
 Why?
Hematocrit
1
1997
94
0.010
 Why?
Socioeconomic Factors
1
2001
1200
0.010
 Why?
Rest
1
1997
123
0.010
 Why?
Electric Conductivity
1
1997
94
0.010
 Why?
Ventricular Fibrillation
1
1997
58
0.010
 Why?
Electrodes, Implanted
1
1997
103
0.010
 Why?
Hyperlipidemias
1
1997
126
0.010
 Why?
Diabetes Complications
1
1997
228
0.010
 Why?
Equipment Design
1
1997
526
0.010
 Why?
Electrocardiography
1
1998
615
0.010
 Why?
Tachycardia, Ventricular
1
1997
170
0.010
 Why?
Multivariate Analysis
1
1998
1510
0.010
 Why?
Kinetics
1
1997
1634
0.010
 Why?
Stroke
1
2002
1119
0.010
 Why?
Heart Arrest
1
1997
328
0.010
 Why?
Survival Rate
1
1997
1904
0.010
 Why?
Length of Stay
1
1997
1135
0.010
 Why?
Energy Metabolism
1
1997
841
0.010
 Why?
Smoking
1
1997
1505
0.010
 Why?
Retrospective Studies
1
2003
14675
0.000
 Why?
DeSouza's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (402) concept(s)
_
Co-Authors Expand Description
See all (15) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)